(19)
(11) EP 2 459 172 A1

(12)

(43) Date of publication:
06.06.2012 Bulletin 2012/23

(21) Application number: 10744770.8

(22) Date of filing: 29.07.2010
(51) International Patent Classification (IPC): 
A61K 9/06(2006.01)
A61K 31/192(2006.01)
A61P 17/10(2006.01)
A61K 31/136(2006.01)
A61K 9/00(2006.01)
(86) International application number:
PCT/US2010/043671
(87) International publication number:
WO 2011/014627 (03.02.2011 Gazette 2011/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 30.07.2009 US 229903 P

(71) Applicant: Allergan, Inc.
Irvine, CA 92612 (US)

(72) Inventors:
  • AHLUWALIA, Gurpreet
    Irvine California 92612 (US)
  • WARNER, Kevin, S.
    Anaheim California 92807 (US)
  • CHEN, Haigang
    Petaluma California 94954 (US)
  • YANG, Meidong
    Richmond California 94801 (US)
  • BEDDINGFIELD, Frederick, C.
    Pacific Pallisades, CA 90272 (US)
  • EHRHARDT, Jeffrey, R.
    San Clemente, CA 92673 (US)

(74) Representative: HOFFMANN EITLE 
Patent- und Rechtsanwälte Arabellastraße 4
81925 München
81925 München (DE)

   


(54) COMBINATION OF DAPSONE WITH ADAPALENE